Skip to content

Clinical Assessment of Two Reusable Silicone Hydrogel Contact Lenses

Clinical Assessment of Two Reusable Silicone Hydrogel Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05050578
Enrollment
166
Registered
2021-09-20
Start date
2021-11-02
Completion date
2022-02-22
Last updated
2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Errors

Keywords

Contact lenses

Brief summary

The purpose of this study is to compare the clinical performance of LID018869 soft contact with ACUVUE® OASYS with HYDRACLEAR® PLUS (AOHP) soft contact lenses over 30 days of daily wear.

Detailed description

Subjects will be expected to attend 6 visits. Subjects will be expected to wear their study contact lenses every day for at least 10 hours per day over a 30-day period for each study lens type. The total duration of a subject's participation in the study will be approximately 65 days.

Interventions

Commercially available, silicone hydrogel, spherical contact lenses used as indicated

Commercially available, silicone hydrogel, spherical contact lenses used as indicated

Hydrogen peroxide-based contact lens cleaning and disinfecting solution

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Current wearer of a commercial spherical weekly/monthly soft contact lenses with at least 3 months of wearing experience, with a minimum wearing time of 5 days per week and 10 hours per day. * Manifest cylinder less than or equal to 0.75 diopter in each eye. * Best corrected distance visual acuity better than or equal to 20/25 Snellen in each eye. * Other protocol-defined inclusion criteria may apply. Key

Exclusion criteria

* Monovision or multifocal lens wearer. * Habitual senofilcon contact lens wearer (for example, Acuvue Oasys, Acuvue Vita) or commercially available lehfilcon A contact lens wearer (TOTAL30). * Routinely sleeps in habitual contact lenses. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Least Squares Mean Distance Visual Acuity With Study Lenses at Day 30Day 30, each study lens typeVisual acuity (VA) was collected for each eye individually with study lenses in place at a distance of 4 meters using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.

Countries

United States

Participant flow

Recruitment details

Subjects were recruited from 10 investigative sites located in the United States.

Pre-assignment details

Of the 166 enrolled, 3 subjects were exited from the study prior to randomization as screen failures, and 1 randomized subject was discontinued prior to exposure to the study lenses. This reporting group includes all subjects exposed to the study lenses, as treated (162).

Participants by arm

ArmCount
LID018869, Then AOHP
Lehfilcon A contact lenses worn in Period 1, followed by senofilcon A contact lenses worn in Period 2, as randomized. Each product was worn in both eyes during waking hours only for at least 10 hours per day for 30 days. CLEAR CARE was used for daily contact lens cleaning and disinfection.
82
AOHP, Then LID018869
Senofilcon A contact lenses worn in Period 1, followed by lehfilcon A contact lenses worn in Period 2, as randomized. Each product was worn in both eyes during waking hours only for at least 10 hours per day for 30 days. CLEAR CARE was used for daily contact lens cleaning and disinfection.
80
Total162

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 1, 30 DaysLost to Follow-up11
Period 1, 30 DaysWithdrawal by Subject10
Period 2, 30 DaysProtocol Violation01

Baseline characteristics

CharacteristicLID018869, Then AOHPAOHP, Then LID018869Total
Age, Continuous32.4 years
STANDARD_DEVIATION 8.2
33.1 years
STANDARD_DEVIATION 8.5
32.8 years
STANDARD_DEVIATION 8.3
Ethnicity (NIH/OMB)
Hispanic or Latino
12 Participants11 Participants23 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
70 Participants69 Participants139 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Asian
20 Participants18 Participants38 Participants
Race/Ethnicity, Customized
Black or African American
5 Participants5 Participants10 Participants
Race/Ethnicity, Customized
Multi-racial
0 Participants2 Participants2 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Other
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
White
56 Participants55 Participants111 Participants
Sex: Female, Male
Female
45 Participants49 Participants94 Participants
Sex: Female, Male
Male
37 Participants31 Participants68 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
0 / 1620 / 3220 / 1610 / 3200 / 160
other
Total, other adverse events
0 / 1620 / 3220 / 1610 / 3200 / 160
serious
Total, serious adverse events
0 / 1620 / 3220 / 1610 / 3200 / 160

Outcome results

Primary

Least Squares Mean Distance Visual Acuity With Study Lenses at Day 30

Visual acuity (VA) was collected for each eye individually with study lenses in place at a distance of 4 meters using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.

Time frame: Day 30, each study lens type

Population: Full Analysis Set: All randomized subjects who were exposed to any study lenses evaluated in this clinical study with data at Day 30.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
LID018869Least Squares Mean Distance Visual Acuity With Study Lenses at Day 30-0.07 logMARStandard Error 0.006
AOHPLeast Squares Mean Distance Visual Acuity With Study Lenses at Day 30-0.07 logMARStandard Error 0.006

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026